Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration

被引：8
|
作者：
Hosoi, Hiroki [1 ]
Mushino, Toshiki [1 ]
Nishikawa, Akinori [1 ]
Hashimoto, Hisako [2 ]
Murata, Shogo [1 ]
Hatanaka, Kazuo [1 ,4 ]
Tamura, Shinobu [1 ]
Hanaoka, Nobuyuki [1 ,5 ]
Shimizu, Norio [3 ]
Sonoki, Takashi [1 ]
机构：
[1] Wakayama Med Univ, Hematol Oncol, Kimiidera 811-1, Wakayama 6418510, Japan
[2] Inst Biomed Res & Innovat, Dept Cell Therapy, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[3] Tokyo Med & Dent Univ, Inst Res, Ctr Stem Cell & Regenerat Med, Div Adv Biomed Engn Res, Tokyo, Japan
[4] Osaka Red Cross Hosp, Dept Hematol, Tennoji Ku, 5-30 Fudegasakicho, Osaka 5438555, Japan
[5] Kumamoto Minami Hosp, Natl Hosp Org, Dept Gen Med, Kumamoto, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2018年 / 107卷 / 06期
关键词：
LEUKEMIA/LYMPHOMA;
D O I：
10.1007/s12185-018-2456-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：717 / 719
页数：3
相关论文
共 50 条
  • [1] Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration
    Hiroki Hosoi
    Toshiki Mushino
    Akinori Nishikawa
    Hisako Hashimoto
    Shogo Murata
    Kazuo Hatanaka
    Shinobu Tamura
    Nobuyuki Hanaoka
    Norio Shimizu
    Takashi Sonoki
    International Journal of Hematology, 2018, 107 : 717 - 719
  • [2] Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease
    Sugio, Takeshi
    Kato, Koji
    Aoki, Takatoshi
    Ohta, Takanori
    Saito, Noriyuki
    Yoshida, Shuro
    Kawano, Ichiro
    Henzan, Hideho
    Kadowaki, Masanori
    Takase, Ken
    Muta, Tsuyoshi
    Miyawaki, Kohta
    Yamauchi, Takuji
    Shima, Takahiro
    Takashima, Shuichiro
    Mori, Yasuo
    Yoshimoto, Goichi
    Kamezaki, Kenjiro
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Ogawa, Ryosuke
    Ohno, Yuju
    Eto, Tetsuya
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Akashi, Koichi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (09) : 1608 - 1614
  • [3] Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Zupan, IP
    Zver, S
    Pretnar, J
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2931 - 2933
  • [4] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [5] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [6] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Omer, Aazim K.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883
  • [7] Prior Use of Mogamulizumab to Allogenic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-Versus-Host Disease
    Sugio, Takeshi
    Kato, Koji
    Aoki, Takatoshi
    Ota, Takanori
    Saito, Noriyuki
    Yoshida, Shuro
    Kawano, Ichiro
    Henzan, Hideho
    Takase, Ken
    Muta, Tsuyoshi
    Miyawaki, Kohta
    Shima, Takahiro
    Takashima, Shuichiro
    Yamauchi, Takuji
    Mori, Yasuo
    Yoshimoto, Goichi
    Kamezaki, Kenjiro
    Takenaka, Katsuto
    Kamimura, Tomohiko
    Ohno, Yuju
    Eto, Tetsuya
    Ogawa, Ryosuke
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Akashi, Koichi
    BLOOD, 2015, 126 (23)
  • [8] Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab
    Kamada, Yuhei
    Arima, Naosuke
    Hayashida, Maiko
    Nakamura, Daisuke
    Yoshimitsu, Makoto
    Ishitsuka, Kenji
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1701 - 1707
  • [9] Impact of cyclosporine A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation
    Mallard, F.
    Brissot, E.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Moreau, P.
    Harousseau, J. L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S137 - S138
  • [10] Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
    Stratton, Pamela
    Turner, Maria L.
    Childs, Richard
    Barrett, John
    Bishop, Michael
    Wayne, Alan S.
    Pavletic, Steven
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (05): : 1041 - 1049
12345